February 16, 2018
Rose
Insulin dose tool gains CE Mark. DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan.
from MobiHealthNews http://ift.tt/2C1C5eT
February 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Leaked memo suggests Nokia's digital health business on the chopping block- Patient-generated health data can be used to improve patients’ health – here’s how
- Mobile health program improved addiction outcomes despite low clinician engagement
- American Well to shine HIMSS18 spotlight on partners as it slides into connector role
- VSP Global launches activity-tracking Level smart glasses
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment